You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 6,352,717


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,352,717
Title: Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses
Abstract:The present invention provides a process for encapsulating a shear sensitive fill mass which contains a pharmaceutical active agent or nutrient, characterized in that said fill mass is heated and subsequently cooled, prior to the encapsulation. The invention also provides capsules comprising shear sensitive fill material obtained by the said process which have a high and constant dissolution rate.
Inventor(s): Alex; Rainer (Weil am Rhein, DE), Gerhards; Jurgen (Arlesheim, CH), Kraemer-Pittrof; Ingeborg (Rheinfelden, DE), Oeschger; Richard (Rheinsulz, CH), Rades; Thomas (Dunedin, NZ)
Assignee: Hoffman-La Roche Inc. (Nutley, NJ)
Application Number:09/440,731
Patent Claim Types:
see list of patent claims
Dosage form; Process; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,352,717: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property, particularly in the pharmaceutical and biotechnology sectors. This article will delve into the specifics of United States Patent 6,352,717, titled "Process for encapsulating shear sensitive fill masses into capsules," and provide a detailed analysis of its scope, claims, and the broader patent landscape.

Overview of the Patent

Title and Abstract

United States Patent 6,352,717, granted on March 5, 2002, describes a process for encapsulating shear-sensitive fill masses into capsules. The patent focuses on a method to protect sensitive materials during the encapsulation process, ensuring the integrity and efficacy of the final product.

Inventors and Assignees

The patent was invented by a team of researchers and assigned to a pharmaceutical company. Understanding the inventors and assignees can provide insights into the development and commercialization of the technology.

Scope of the Patent

Technical Background

The patent addresses a specific challenge in pharmaceutical manufacturing: the encapsulation of shear-sensitive materials. Shear sensitivity refers to the tendency of materials to degrade or lose their properties when subjected to mechanical stress, such as during the encapsulation process. The patented process aims to mitigate this issue through a novel method of encapsulation.

Claims

The claims of a patent define the scope of the invention and what is protected by the patent. For US Patent 6,352,717, the claims can be broadly categorized into:

Independent Claims

These claims stand alone and define the core invention. They typically include the essential features of the process, such as the specific steps involved in encapsulating the shear-sensitive fill masses.

Dependent Claims

These claims build upon the independent claims and provide additional details or variations of the invention. They may include specific materials, equipment, or conditions under which the process is carried out.

Claim Analysis

To understand the scope of the patent, it is essential to analyze each claim carefully. Here are some key aspects to consider:

Claim Coverage Matrix

Using a Claim Coverage Matrix, as described by Schwegman’s process, can help categorize the claims by their scope concepts. This matrix can identify which claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Scope Concepts

The claims can be categorized by overarching scope concepts, such as the type of fill mass, the encapsulation method, and the equipment used. This categorization helps in filtering, searching, and analyzing large numbers of patent claims concurrently[3].

Patent Landscape Analysis

Priority Patent Applications

To understand the broader patent landscape, it is crucial to identify the priority patent applications related to US Patent 6,352,717. This involves searching databases like Esp@ceNet, which compiles application numbers, dates, and applicants from over 70 million patent documents worldwide[1].

Patent Families

The priority patent data is used to search for the corresponding patent families. A patent family includes similar patent documents filed in different jurisdictions, all deriving from the same priority patent application. This helps in tracking where else in the world similar patent applications have been filed and granted[1].

Regional and National Patent Offices

The patent status at regional and national patent offices, such as the USPTO, EPO, or other relevant offices, needs to be verified. This ensures that the patent is valid and enforceable in various jurisdictions.

Transparency and Accessibility of Patent Information

Publicly Available Lists

Patent information, including that related to US Patent 6,352,717, is publicly available through databases like the US FDA Orange Book and Health Canada Patent Registry. These databases provide detailed information on approved pharmaceutical products and the patents claimed as relevant to them[1][2].

Esp@ceNet and INPADOC

Databases like Esp@ceNet and INPADOC are essential tools for patent searches. Esp@ceNet provides free access to patent information from over 70 million patent documents worldwide, while INPADOC compiles patent family information for about 95% of all published patents globally[1].

Limitations and Challenges

Methodology Limitations

The methodology for determining the patent landscape and analyzing claims has its limitations. For instance, the accuracy of the data depends on the quality of the sources and the thoroughness of the search. Cross-checking data from multiple sources is crucial to ensure accuracy[1].

Interpretation of Claims

Interpreting patent claims can be complex and may require legal and technical expertise. The scope of the claims must be carefully analyzed to avoid infringement and to identify potential gaps in coverage[3].

Industry Impact and Applications

Pharmaceutical Manufacturing

The process described in US Patent 6,352,717 has significant implications for pharmaceutical manufacturing. It addresses a critical issue in the production of capsules containing shear-sensitive materials, ensuring the quality and efficacy of the final product.

Future Developments

Understanding the scope and claims of this patent can also guide future developments in pharmaceutical technology. By identifying gaps in current coverage, companies can explore new design options and improve their manufacturing processes[3].

Key Takeaways

  • Detailed Claim Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the patent.
  • Patent Landscape: Identifying priority patent applications and patent families helps in tracking similar patents globally.
  • Transparency: Publicly available databases like Esp@ceNet and INPADOC are vital for patent searches.
  • Industry Impact: The patented process has significant implications for pharmaceutical manufacturing, particularly in ensuring the quality of shear-sensitive materials.
  • Future Developments: Analyzing the claims and patent landscape can guide future innovations and improvements in pharmaceutical technology.

FAQs

What is the main focus of US Patent 6,352,717?

The main focus of US Patent 6,352,717 is a process for encapsulating shear-sensitive fill masses into capsules, ensuring the integrity and efficacy of the final product.

How can the scope of the patent be analyzed?

The scope of the patent can be analyzed using a Claim Coverage Matrix, categorizing claims by their scope concepts, and identifying which claims are actively protecting the intellectual property.

What databases are useful for patent searches related to this patent?

Databases like Esp@ceNet, INPADOC, the US FDA Orange Book, and Health Canada Patent Registry are useful for patent searches and verifying the patent status.

Why is transparency of patent information important?

Transparency of patent information is crucial as it ensures that the public disclosure of an invention is available, which is a condition of the patent grant. This transparency promotes innovation and prevents "free-riding" copiers[1].

How can companies use this patent analysis for future developments?

Companies can use this patent analysis to identify gaps in current coverage, explore new design options, and improve their manufacturing processes, thereby guiding future innovations in pharmaceutical technology[3].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,352,717

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,352,717

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
98121831Nov 17, 1998

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.